Bernhard J Jank, Julia Schnoell, Katharina Kladnik, Carmen Sparr, Markus Haas, Elisabeth Gurnhofer, Alexander L Lein, Markus Brunner, Lukas Kenner, Lorenz Kadletz-Wanke, Gregor Heiduschka
OBJECTIVES: The transforming growth factor-Beta (TGF-ß) pathway may be involved in the radioresistance of head and neck squamous cell carcinoma (HNSCC). This study analyzed TGF-ß receptor 1 (TGFBR1) expression in HNSCC patients and evaluated the antineoplastic and radiosensitizing effects of vactosertib, a novel TGFBR1 inhibitor, in vitro. MATERIALS AND METHODS: TGFBR1 expression was examined in HNSCC patients at the mRNA level in silico and the protein level by immunohistochemistry, including surgical specimens of primary tumors, matched lymph node metastasis, and recurrent disease...
May 8, 2023: Oral Diseases